This seems to fit a pattern I am seeing with gapped down biotech stocks, buying to fill in the gap above. It's only as risky as the amount of shares bought, the stop and target levels are defined. Looks like to me it wants to go up, just broke above the peak from last week.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.